Trial Outcomes & Findings for Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors (NCT NCT02383420)

NCT ID: NCT02383420

Last Updated: 2016-04-15

Results Overview

1-Non-diagnostic Unacceptable for diagnostic purposes. Little or no clinically usable diagnostic information (e.g., gross underexposure, system failure or extensive motion artifact). Almost all such imaging should be repeated. 2-Limited Acceptable, with some technical defect (motion artifact, body habitus/poor x-ray penetration, or patient positioning may limit visualization of some body-regions but still adequate for diagnostic purposes). Not as much diagnostic information as is typical for an examination of this type, but likely sufficient. 3-Diagnostic Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary Good, most adequate for diagnostic purposes. Image quality that can serve as an example that should be emulated.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

9 weeks after last x-ray capture

Results posted on

2016-04-15

Participant Flow

Participant milestones

Participant milestones
Measure
Predicate & Invest.-GOS
Each subject will receive one x-ray using the predicate detector and one x-ray using the GOS investigational detector.
Predicate & Invest.-CsI
Each subject will receive one x-ray using the predicate detector and one x-ray using the CsI investigational detector.
Predicate & Investigational-Cadavers
Radiation - Multiple exams (head, chest, legs, etc) were made on the cadavers. Each exam area received one x-ray using the predicate detector and two x-rays using both the GoS and the CsI investigational detector.
Overall Study
STARTED
10
10
3
Overall Study
COMPLETED
8
10
3
Overall Study
NOT COMPLETED
2
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Predicate & Invest.-GOS
n=8 Participants
Each subject will receive one x-ray using the predicate detector and one x-ray using the GOS investigational detector.
Predicate & Invest.-CsI
n=10 Participants
Radiation - Each subject will receive one x-ray using the predicate detector and one x-ray using the CsI investigational detector.
Predicate & Invest.-Cadavers GOS & CsI
n=3 Participants
Radiation - Multiple exams (head, chest, legs, etc) were made on the cadavers. Each exam area received one x-ray using the predicate detector and two x-rays using both the GoS and the CsI investigational detector.
Total
n=21 Participants
Total of all reporting groups
Age, Customized
21 years and older
8 participants
n=5 Participants
10 participants
n=7 Participants
3 participants
n=5 Participants
21 participants
n=4 Participants
Sex/Gender, Customized
Unknown
8 participants
n=5 Participants
10 participants
n=7 Participants
3 participants
n=5 Participants
21 participants
n=4 Participants

PRIMARY outcome

Timeframe: 9 weeks after last x-ray capture

Population: A total of 177 image pairs were included for the reader study. Of the 177 pairs, 160 were cadaver image pairs. A total of seventeen (17) adult live human subject pairs were included in the reader study.

1-Non-diagnostic Unacceptable for diagnostic purposes. Little or no clinically usable diagnostic information (e.g., gross underexposure, system failure or extensive motion artifact). Almost all such imaging should be repeated. 2-Limited Acceptable, with some technical defect (motion artifact, body habitus/poor x-ray penetration, or patient positioning may limit visualization of some body-regions but still adequate for diagnostic purposes). Not as much diagnostic information as is typical for an examination of this type, but likely sufficient. 3-Diagnostic Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary Good, most adequate for diagnostic purposes. Image quality that can serve as an example that should be emulated.

Outcome measures

Outcome measures
Measure
Predicate
n=177 images
DRX-1 Detector, Live Subjects and Cadavers
Investigational
n=177 images
DRX PRO 3543/C (GOS \& CsI) Detectors, Live Subjects \& Cadavers
Radlex Scale for Diagnostic Capability Ratings
3.0610 units on a scale
Standard Error 0.0140
3.0633 units on a scale
Standard Error 0.0141

SECONDARY outcome

Timeframe: 9 weeks after last x-ray capture

Population: cadavers and live human subjects

During the Reader Study the radiologists completed a paired preference rating using the following scale: -3, Image displayed on left is strongly preferred; -2, Image displayed on left is moderately preferred; -1, Image displayed on left is slightly preferred; 0, No preference between the images; 1, Image displayed on right is slightly preferred; 2, Image displayed on right is moderately preferred; 3, Image displayed on right is strongly preferred. Both the predicate and investigational images were randomly assigned to appear on the right or left monitors. A spreadsheet was used for managing the data. Prior to analysis, raw ratings were converted so that those in favor of the investigational device were made positive, and ratings in favor of the predicate device were made negative.

Outcome measures

Outcome measures
Measure
Predicate
n=177 units
DRX-1 Detector, Live Subjects and Cadavers
Investigational
DRX PRO 3543/C (GOS \& CsI) Detectors, Live Subjects \& Cadavers
Pair Preference Rating Scale
0.1333 units on a scale
Standard Error 0.0209

Adverse Events

Predicate & Invest.-GOS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Predicate & Invest.-CsI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Predicate & Invest.-Cadavers GOS & CsI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Susan Pate, Senior Clinical Affairs Manager

Carestream Health, Inc.

Phone: 585-627-6557

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place